{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:35:34Z","timestamp":1792290934960,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijrobp.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T20:19:53Z","timestamp":1704745193000},"page":"1552-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy"],"prefix":"10.1016","volume":"118","author":[{"given":"Julian P.","family":"Layer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Shiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Guedes","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motaz","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cas S.","family":"Dejonckheere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Cifarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea L.","family":"Friker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Herrlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard Christopher","family":"Schmeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cifarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-7270","authenticated-orcid":false,"given":"Gustavo R.","family":"Sarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Henning","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.01.009_bib0001","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0003","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0004","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0005","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0006","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/neuonc\/now197","article-title":"Systemic therapy of brain metastases: Non-small cell lung cancer, breast cancer, and melanoma","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0007","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clgc.2012.01.004","article-title":"Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: Abscopal effect prevented by the blood-brain barrier?","volume":"10","author":"Ishiyama","year":"2012","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0008","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13046-019-1426-2","article-title":"Immunotherapy of brain metastases: Breaking a \u201cdogma","volume":"38","author":"Di Giacomo","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0009","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2011.10.018","article-title":"Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically","volume":"83","author":"Yamamoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0010","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.3390\/ijms14058708","article-title":"Surgical resection of brain metastases\u2014impact on neurological outcome","volume":"14","author":"Sch\u00f6del","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11060-019-03186-z","article-title":"Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery","volume":"143","author":"Verhaak","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0012","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: A single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0014","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jamaoncol.2020.4630","article-title":"Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases","volume":"6","author":"Eitz","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): A multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11060-019-03309-6","article-title":"Intraoperative radiotherapy (IORT) for surgically resected brain metastases: Outcome analysis of an international cooperative study","volume":"145","author":"Cifarelli","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00066-021-01831-z","article-title":"Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases-an Augsburg University Medical Center experience","volume":"197","author":"Kahl","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/cancers15010014","article-title":"Low-Energy X-Ray Intraoperative Radiation Therapy (Lex-IORT) for resected brain metastases: A single-institution experience","volume":"15","author":"Diehl","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11060-023-04380-w","article-title":"Outcome assessment of intraoperative radiotherapy for brain metastases: Results of a prospective observational study with comparative matched-pair analysis","volume":"164","author":"Layer","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.759873","article-title":"Dosimetric comparison of upfront boosting with stereotactic radiosurgery versus intraoperative radiotherapy for glioblastoma","volume":"11","author":"Sarria","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0021","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/cancers14061515","article-title":"Benchmarking safety indicators of surgical treatment of brain metastases combined with intraoperative radiotherapy: Results of prospective observational study with comparative matched-pair analysis","volume":"14","author":"Hamed","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.1071804","article-title":"Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort","volume":"9","author":"Krauss","year":"2022","journal-title":"Front Surg."},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0023","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","article-title":"Combining radiotherapy and immunotherapy: A revived partnership","volume":"63","author":"Demaria","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0024","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: A beneficial liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0027","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0028","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: Proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0029","doi-asserted-by":"crossref","first-page":"e28780","DOI":"10.4161\/onci.28780","article-title":"Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy","volume":"3","author":"Grimaldi","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15384047.2016.1264543","article-title":"Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone","volume":"18","author":"Koller","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0032","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/1759-7714.13048","article-title":"Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review","volume":"10","author":"Lin","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0033","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.21037\/jtd-2019-rbmlc-08","article-title":"Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer","volume":"13","author":"Suwinski","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0034","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0036","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2159-8290.CD-21-0976","article-title":"Tumor immune microenvironment of brain metastases: Toward unlocking antitumor immunity","volume":"12","author":"Strickland","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0037","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138740","article-title":"Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control","volume":"131","author":"Lhuillier","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0038","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0039","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.trecan.2019.06.003","article-title":"Improving CNS delivery to brain metastases by blood-tumor barrier disruption","volume":"5","author":"Sprowls","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102611118","article-title":"Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads","volume":"118","author":"Lussier","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0041","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3 \u00d7 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0042","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3171\/2022.7.JNS22752","volume":"138","author":"Lehrer","year":"2022","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0043","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3390\/curroncol30020101","article-title":"Five-fraction stereotactic radiotherapy for brain metastases - a retrospective analysis","volume":"30","author":"Layer","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109920","article-title":"Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy","volume":"189","author":"Hall","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2012.01.067","article-title":"Tumor bed dynamics after surgical resection of brain metastases: Implications for postoperative radiosurgery","volume":"84","author":"Jarvis","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0046","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-07-4453","article-title":"Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding","volume":"14","author":"Belletti","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0047","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2012.08.005","article-title":"Relative biologic effectiveness (RBE) of 50 kV x-rays measured in a phantom for intraoperative tumor-bed irradiation","volume":"85","author":"Liu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13014-016-0750-3","article-title":"Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects","volume":"12","author":"Herskind","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0049","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11060-023-04464-7","article-title":"Intraoperative or postoperative stereotactic radiotherapy for brain metastases: Time to systemic treatment onset and other patient-relevant outcomes","volume":"164","author":"Dejonckheere","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002261","article-title":"Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer","volume":"9","author":"Maslov","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0051","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctrv.2016.11.013","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review","volume":"53","author":"Kroeze","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0052","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/COC.0000000000000199","article-title":"Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases","volume":"40","author":"Patel","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0053","article-title":"Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis","volume":"39","author":"Bodensohn","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0054","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cllc.2016.10.009","article-title":"Treatment design and rationale for a randomized trial of cisplatin and etoposide plus thoracic radiotherapy followed by nivolumab or placebo for locally advanced non\u2013small-cell lung cancer (RTOG 3505)","volume":"18","author":"Gerber","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0055","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.ijrobp.2017.06.303","article-title":"Combined immune checkpoint blockade and radiation therapy: Timing and dose fractionation associated with greatest survival duration among over 750 treated patients","volume":"99","author":"Samstein","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0056","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2011.09.025","article-title":"Incidence, risk factors and management of delayed wound dehiscence after craniotomy for tumor resection","volume":"19","author":"Barami","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.662943","article-title":"Surgical and peri-operative considerations for brain metastases","volume":"11","author":"Gupta","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0058","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hed.26601","article-title":"Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer","volume":"43","author":"Mays","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.01.009_bib0059","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SAP.0b013e31824e5e57","article-title":"Bevacizumab and wound-healing complications: Mechanisms of action, clinical evidence, and management recommendations for the plastic surgeon","volume":"71","author":"Sharma","year":"2013","journal-title":"Ann Plast Surg"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:12:33Z","timestamp":1759745553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162400018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S036030162400018X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}